Thermo Fisher to buy Patheon for $5.2 billion to expand biopharma services – Reuters


Reuters
Thermo Fisher to buy Patheon for $5.2 billion to expand biopharma services
Reuters
Thermo Fisher Scientific Inc (TMO.N) said on Monday it would buy Patheon NV (PTHN.N), a Dutch manufacturer of drugs for clinical trials, for $5.2 billion as it seeks to complement its offerings in production and services for the biopharma industry. The

and moreĀ >>

Source: services – Google News

Sharing information is key – Social Media Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd